Cardiology

The Biology of Your Heart's Electrical Wiring

At a Glance

This inherited condition is caused by gene changes that can make the heart beat too fast in the atria, slow or block signals below the Bundle of His, and sometimes thicken or weaken the heart muscle. The gene involved can guide monitoring of both rhythm and heart structure.

While many heart rhythm problems are caused by aging, high blood pressure, or lifestyle factors, Hereditary atrial tachyarrhythmia-infra-Hisian cardiac conduction disease is different. It is a condition built into your biology, caused by pathogenic variants in the genetic code that build and power your heart’s electrical system ^[1]^[2].

Understanding the biology of your condition helps explain why your heart can sometimes race while at other times it struggles to send signals at all.

The Anatomy of the Infra-Hisian System

To understand “infra-Hisian,” imagine your heart’s electrical system as a series of highways. The Bundle of His is the main junction box that receives signals from the top of the heart. The “infra-Hisian” area is everything below that box, including:

Bundle Branches: The left and right “main roads” that carry electricity into each side of the heart ^[3].
Fascicles: Smaller divisions of these roads that spread the signal further.
Purkinje Fibers: A fine, spiderweb-like network that finally delivers the “spark” to your heart muscle cells, telling them to squeeze ^[4]^[5].

In your condition, these highways conduct signals too slowly (a conduction delay) or hit a dead end (a block) ^[6]^[7].

The Role of Your Specific Genes

Different genes can cause this condition, and which one you have determines whether the problem is strictly “electrical” or if it also affects the “bricks and mortar” of your heart muscle.

SCN5A: The Sodium Channel “Gatekeeper”

The SCN5A gene provides instructions for making sodium channels (specifically Nav1.5). These channels act like tiny gates on the surface of your heart cells. When they open, sodium rushes in, creating the electrical “spark” (the action potential) that makes the heart beat ^[8]^[9].

What happens: Depending on the variant, mutations in this gene can cause a “loss of function” or “gain of function,” meaning the gates don’t open or close properly ^[10].
The Result: Without the proper “spark,” the signal moves slowly through the atria (leading to AFib) and crawls through the infra-Hisian highways ^[8]^[11].

PRKAG2: The Energy Sensor

The PRKAG2 gene is different; it helps your heart cells sense and use energy.

What happens: Pathogenic variants here lead the heart to store abnormal amounts of sugar (glycogen) inside the muscle cells ^[12]^[13].
The Result: The syndrome includes ventricular pre-excitation, glycogen storage, and causes the heart walls to become thick and stiff (hypertrophy), alongside progressive conduction blocks ^[14]^[15].

Other Important Genes

LMNA: This gene provides structural support to the “nucleus” (the brain) of your heart cells. Mutations here often lead to Dilated Cardiomyopathy, where the heart becomes enlarged and weak, alongside severe electrical blocks and ventricular arrhythmias ^[16]^[17].
TRPM4: This gene controls different electrical “gates.” Mutations can cause the wiring to conduct poorly over time, even if the heart muscle itself looks normal ^[6]^[18].
TNNI3K: This gene is linked to a mix of fast atrial rhythms and progressive heart block, sometimes also affecting how the heart muscle contracts ^[19]^[20].

Genetic vs. Acquired Disease

It is common for people to confuse this condition with “standard” Atrial Fibrillation (AFib) or heart block seen in older adults. However, there are key differences:

Age of Onset: Acquired heart block can happen at any age from medications, ischemia, myocarditis, or wear and tear. However, inherited genetic forms are an important cause to consider when symptoms appear much earlier, sometimes in childhood or young adulthood ^[1]^[2].
Structural Changes: In non-genetic AFib, the heart is often damaged by high blood pressure or valve disease. In genetic conditions like PRKAG2 or LMNA, the structural changes are caused directly by the mutation itself ^[21]^[16].
Family History: Because this is hereditary, you may see a pattern of “early pacemakers” or unexplained fainting across generations of your family tree ^[19].

Knowing which gene is involved is like knowing the “make and model” of your condition—it helps your doctors predict whether the problem will stay purely electrical or if they need to monitor the strength and thickness of your heart muscle as well.

Common questions in this guide

What is hereditary cardiac conduction disease?

It is an inherited heart rhythm condition caused by a genetic change that affects the heart’s electrical wiring. It can cause fast rhythms in the atria as well as slowed or blocked signals below the Bundle of His.

What does infra-Hisian mean in this condition?

Infra-Hisian refers to the part of the heart’s electrical system below the Bundle of His. It includes the bundle branches, fascicles, and Purkinje fibers, where electrical signals may become delayed or blocked.

How can different genes cause different heart problems?

SCN5A affects sodium channels that help create the heart’s electrical signal. PRKAG2 can cause abnormal glycogen storage, early electrical activation, and thickened heart muscle, while genes such as LMNA, TRPM4, and TNNI3K can cause other combinations of rhythm and conduction problems.

Can this inherited condition affect the heart muscle as well as its rhythm?

Yes, depending on the gene involved. Some variants mainly affect electrical signals, while others can cause a thickened and stiff heart, an enlarged and weakened heart, or changes in how strongly it contracts.

How is this different from ordinary atrial fibrillation or age-related heart block?

Inherited forms may begin in childhood, young adulthood, or earlier than typical acquired disease and may affect several relatives. The genetic change can directly cause both the electrical problem and, in some cases, structural changes in the heart.

Why might genetic testing change my heart monitoring plan?

Identifying the specific variant can show whether the condition is likely to remain mainly electrical or also affect heart muscle structure. That information may help the care team decide how often rhythm checks, echocardiograms, or cardiac MRI are appropriate.

Get notified when new evidence is published on Hereditary atrial tachyarrhythmia-infra-Hisian cardiac conduction disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (21)

1
Molecular and genetic insights into progressive cardiac conduction disease.
Asatryan B, Medeiros-Domingo A
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2019; (21(8)):1145-1158 doi:10.1093/europace/euz109.
PMID: 31087102
2
Cardiac conduction disorders in young adults: Clinical characteristics and genetic background of an underestimated population.
Balla C, Margutti A, De Carolis B, et al.
Heart rhythm 2024; (21(8)):1363-1369 doi:10.1016/j.hrthm.2024.03.008.
PMID: 38467355
3
The normal variants in the left bundle branch system.
Elizari MV
Journal of electrocardiology 2017; (50(4)):389-399 doi:10.1016/j.jelectrocard.2017.03.004.
PMID: 28341304
4
Unsolved Questions on the Anatomy of the Ventricular Conduction System.
Oh IY, Cha MJ, Lee TH, et al.
Korean circulation journal 2018; (48(12)):1081-1096 doi:10.4070/kcj.2018.0335.
PMID: 30403014
5
The QRS Complex: Normal Activation of the Ventricles.
Bagliani G, De Ponti R, Gianni C, Padeletti L
Cardiac electrophysiology clinics 2017; (9(3)):453-460 doi:10.1016/j.ccep.2017.05.005.
PMID: 28838550
6
Transient receptor potential melastatin 4 cation channel in pediatric heart block.
Tian J, An XJ, Fu MY
European review for medical and pharmacological sciences 2017; (21(4 Suppl)):79-84.
PMID: 29165759
7
Fascicular Blocks: Update 2019.
Elizari MV
Current cardiology reviews 2021; (17(1)):31-40 doi:10.2174/1573403X16666200708111928.
PMID: 32640960
8
Biophysical mechanisms of myocardium sodium channelopathies.
Zaytseva AK, Kulichik OE, Kostareva AA, Zhorov BS
Pflugers Archiv : European journal of physiology 2024; (476(5)):735-753 doi:10.1007/s00424-024-02930-3.
PMID: 38424322
9
Heritable arrhythmia syndromes associated with abnormal cardiac sodium channel function: ionic and non-ionic mechanisms.
Rivaud MR, Delmar M, Remme CA
Cardiovascular research 2020; (116(9)):1557-1570 doi:10.1093/cvr/cvaa082.
PMID: 32251506
10
SCN5A-L256del and L1621F exhibit loss-of-function properties related to autosomal recessive congenital cardiac disorders presenting as sick sinus syndrome, dilated cardiomyopathy, and sudden cardiac death.
Shi J, Pan X, Wang Z, et al.
Gene 2024; (898()):148093 doi:10.1016/j.gene.2023.148093.
PMID: 38123004
11
Development of a Patient-Derived Induced Pluripotent Stem Cell Model for the Investigation of SCN5A-D1275N-Related Cardiac Sodium Channelopathy.
Hayano M, Makiyama T, Kamakura T, et al.
Circulation journal : official journal of the Japanese Circulation Society 2017; (81(12)):1783-1791 doi:10.1253/circj.CJ-17-0064.
PMID: 28637969
12
Intrafamilial Phenotypical Variability Linked to PRKAG2 Mutation-Family Case Report and Review of the Literature.
Marcu AS, Vătăşescu R, Onciul S, et al.
Life (Basel, Switzerland) 2022; (12(12)) doi:10.3390/life12122136.
PMID: 36556501
13
Human γ2-AMPK Mutations.
Yavari A, Sarma D, Sternick EB
Methods in molecular biology (Clifton, N.J.) 2018; (1732()):581-619 doi:10.1007/978-1-4939-7598-3_37.
PMID: 29480501
14
Establishment of a PRKAG2 cardiac syndrome disease model and mechanism study using human induced pluripotent stem cells.
Zhan Y, Sun X, Li B, et al.
Journal of molecular and cellular cardiology 2018; (117()):49-61 doi:10.1016/j.yjmcc.2018.02.007.
PMID: 29452156
15
Cardiac manifestations of PRKAG2 mutation.
Banankhah P, Fishbein GA, Dota A, Ardehali R
BMC medical genetics 2018; (19(1)):1 doi:10.1186/s12881-017-0512-6.
PMID: 29298659
16
Lamin and the heart.
Captur G, Arbustini E, Bonne G, et al.
Heart (British Cardiac Society) 2018; (104(6)):468-479 doi:10.1136/heartjnl-2017-312338.
PMID: 29175975
17
LMNA Deficiency Reveals a Role for SK3 Channel Dysfunction in Atrioventricular Block.
Li T, Wang X, Song J, et al.
JACC. Clinical electrophysiology 2026; doi:10.1016/j.jacep.2026.06.035.
PMID: 42569976
18
Inherited Cardiac Arrhythmia Syndromes: Focus on Molecular Mechanisms Underlying TRPM4 Channelopathies.
Amarouch MY, El Hilaly J
Cardiovascular therapeutics 2020; (2020()):6615038 doi:10.1155/2020/6615038.
PMID: 33381229
19
Supraventricular tachycardias, conduction disease, and cardiomyopathy in 3 families with the same rare variant in TNNI3K (p.Glu768Lys).
Podliesna S, Delanne J, Miller L, et al.
Heart rhythm 2019; (16(1)):98-105 doi:10.1016/j.hrthm.2018.07.015.
PMID: 30010057
20
Genetic Burden of TNNI3K in Diagnostic Testing of Patients With Dilated Cardiomyopathy and Supraventricular Arrhythmias.
Pham C, Andrzejczyk K, Jurgens SJ, et al.
Circulation. Genomic and precision medicine 2023; (16(4)):328-336 doi:10.1161/CIRCGEN.122.003975.
PMID: 37199186
21
Clinical Features and Natural History of PRKAG2 Variant Cardiac Glycogenosis.
Lopez-Sainz A, Dominguez F, Lopes LR, et al.
Journal of the American College of Cardiology 2020; (76(2)):186-197 doi:10.1016/j.jacc.2020.05.029.
PMID: 32646569

This page explains the genetic and electrical basis of hereditary cardiac conduction disease for educational purposes only and does not replace medical advice. Discuss your specific variant, rhythm monitoring, and imaging plan with a cardiologist or genetics specialist.